Gamida Cell Stock Quote GMDA - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

0.0327

Bid

0.0302

Ask

0.0304

Volume

0.00 Day's Range 0.00

0.0303 52 Week Range 2.51

Market Cap

3.979M

Previous Close

0.0327

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

11,541,306

Shares Outstanding

132,638,514

Dividend Yield

PE Ratio

-0.06

Earnings Per Share (EPS)

-0.47

Revenue

1.78M

Net Profit

-63M

Gamida Cell Ltd is a biopharmaceutical company involved in developing advanced cell therapies with the potential to cure cancer and rare, serious hematologic diseases. The company's product includes NiCord that is a cell therapy based on NAM-expanded cord blood designed to enhance and expand the lif... Gamida Cell Ltd is a biopharmaceutical company involved in developing advanced cell therapies with the potential to cure cancer and rare, serious hematologic diseases. The company's product includes NiCord that is a cell therapy based on NAM-expanded cord blood designed to enhance and expand the life-saving benefits of hematopoietic stem cell transplant. It is also developing GDA-201 which is innate immunotherapy of expanded natural killer cells, for the treatment of refractory non-Hodgkin lymphoma and multiple myeloma. It is developing a diverse pipeline of cell therapies using its proprietary NAM technology that has the potential to bring life-saving treatment options to patients. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.gamida-cell.com

Headquarters

Jerusalem, Jerusalem, Isr

Founded

1970

Gamida Cell Ltd is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker GMDA. The last closing price for Gamida Cell was $0.03. Over the last year, Gamida Cell shares have traded in a share price range of $ 0.0303 to $ 2.51.

Gamida Cell currently has 132,638,514 shares outstanding. The market capitalization of Gamida Cell is $3.98 million. Gamida Cell has a price to earnings ratio (PE ratio) of -0.06.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	-0.0031	-8.65921787709	0.0358	0.0579	0.0303	44078613	0.04035389	CS
12	-0.3373	-91.1621621622	0.37	0.431	0.0303	11541306	0.09221438	CS
26	-0.7543	-95.8449809403	0.787	0.86	0.0303	6646673	0.17400925	CS
52	-1.5073	-97.8766233766	1.54	2.51	0.0303	4088875	0.52736363	CS
156	-7.6073	-99.5719895288	7.64	7.9	0.0303	1988410	1.12666086	CS
260	-8.3973	-99.6120996441	8.43	15	0.0303	1295853	1.75061971	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BDRXBiodexa Pharmaceuticals PLC	$ 1.3003 (79.40%)	54.46M
NIVFNewGenIvf Group Ltd	$ 2.0899 (60.76%)	46.93M
RCONRecon Technology Ltd	$ 0.126 (53.66%)	5.58M
FCUVFocus Universal Inc	$ 0.41 (44.83%)	15.57M
PEGYPineapple Energy Inc	$ 0.0735 (41.62%)	250.12M
ISUNiSun Inc	$ 0.1585 (-95.40%)	7.42M
NWGLNature Wood Group Ltd	$ 7.66 (-54.54%)	379.52k
ICLKiClick Interactive Asia Group Ltd	$ 1.35 (-46.64%)	532.41k
NUWENewellis Inc	$ 0.1671 (-42.18%)	13.72M
LGHLWLion Group Holding Ltd	$ 0.0055 (-28.57%)	13.27k
PEGYPineapple Energy Inc	$ 0.0735 (41.62%)	250.12M
SQQQProShares UltraPro Short QQQ	$ 11.44 (-4.67%)	74.4M
INTCIntel Corporation	$ 31.78 (-9.48%)	58.87M
BDRXBiodexa Pharmaceuticals PLC	$ 1.3003 (79.40%)	54.46M
NIVFNewGenIvf Group Ltd	$ 2.0899 (60.76%)	46.93M